Human medicines European public assessment report (EPAR): Entecavir Mylan, entecavir, Hepatitis B, Date of authorisation: 18/09/2017, Revision: 1, Status: Authorised

Case Medical Research ◽

10.31525/cmr-116dee1 ◽

2019 ◽

Author(s):

Keyword(s):

Hepatitis B ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Baraclude, entecavir, Hepatitis B, Chronic, Date of authorisation: 26/06/2006, Revision: 24, Status: Authorised

Case Medical Research ◽

10.31525/cmr-134bca4 ◽

2019 ◽

Author(s):

Keyword(s):

Hepatitis B ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Entecavir Mylan, entecavir, Hepatitis B, Date of authorisation: 18/09/2017, Revision: 1, Status: Authorised

Case Medical Research ◽

10.31525/cmr-1177174 ◽

2019 ◽

Author(s):

Keyword(s):

Hepatitis B ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): IntronA, interferon alfa-2b, Carcinoid Tumor,Leukemia, Hairy Cell,Lymphoma, Follicular,Hepatitis B, Chronic,Hepatitis C, Chronic,Leukemia, Myelogenous, Chronic, BCR-ABL Positive,Melanoma,Multiple Myeloma, Date of authorisation: 09/03/2000, Revision: 31, Status: Authorised

Case Medical Research ◽

10.31525/cmr-39964f ◽

2019 ◽

Author(s):

Keyword(s):

Multiple Myeloma ◽

Chronic Hepatitis ◽

Hepatitis C ◽

Hepatitis B ◽

Cell Lymphoma ◽

Interferon Alfa ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Viread, tenofovir disoproxil, Hepatitis B, Chronic,HIV Infections, Date of authorisation: 04/02/2002, Revision: 51, Status: Authorised

Case Medical Research ◽

10.31525/cmr-39964c ◽

2019 ◽

Author(s):

Keyword(s):

Hepatitis B ◽

Hiv Infections ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): IntronA, interferon alfa-2b, Carcinoid Tumor,Leukemia, Hairy Cell,Lymphoma, Follicular,Hepatitis B, Chronic,Hepatitis C, Chronic,Leukemia, Myelogenous, Chronic, BCR-ABL Positive,Melanoma,Multiple Myeloma, Date of authorisation: 09/03/2000, Revision: 31, Status: Authorised

Case Medical Research ◽

10.31525/cmr-fcd076 ◽

2019 ◽

Author(s):

Keyword(s):

Multiple Myeloma ◽

Chronic Hepatitis ◽

Hepatitis C ◽

Hepatitis B ◽

Cell Lymphoma ◽

Interferon Alfa ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Infanrix Hexa, diphtheria (D), tetanus (T), pertussis (acellular, component) (Pa), hepatitis B (rDNA) (HBV), poliomyelitis (inactivated) (IPV) and Haemophilus influenzae type-b (Hib) conjugate vaccine (adsorbed), Hepatitis B,Tetanus,Immunization,Meningitis, Haemophilus,Whooping Cough,Poliomyelitis,Diphtheria, Date of authorisation: 23/10/2000, Revision: 40, Status: Authorised

Case Medical Research ◽

10.31525/cmr-ea7c1c ◽

2019 ◽

Author(s):

Keyword(s):

Hepatitis B ◽

Haemophilus Influenzae ◽

Whooping Cough ◽

Haemophilus Influenzae Type ◽

Haemophilus Influenzae Type B ◽

Type B ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Tetanus Immunization

Download Full-text

Human medicines European public assessment report (EPAR): Twinrix Adult, hepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed), Hepatitis B,Hepatitis A,Immunization, Date of authorisation: 19/09/1996, Revision: 20, Status: Authorised

Case Medical Research ◽

10.31525/cmr-4e9a80 ◽

2018 ◽

Author(s):

Keyword(s):

Hepatitis B ◽

Hepatitis A ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): HBVaxPro, hepatitis-B vaccine (rDNA), Hepatitis B,Immunization, Date of authorisation: 27/04/2001, Revision: 25, Status: Authorised

Case Medical Research ◽

10.31525/cmr-1039ad0 ◽

2019 ◽

Author(s):

Keyword(s):

Hepatitis B ◽

Hepatitis B Vaccine ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Hexyon, diphtheria (D), tetanus (T), pertussis (acellular, component) (Pa), hepatitis B (rDNA) (HBV), poliomyelitis (inactivated) (IPV) and Haemophilus influenzae type b (Hib) conjugate vaccine (adsorbed), Hepatitis B,Tetanus,Immunization,Meningitis, Haemophilus,Whooping Cough,Poliomyelitis,Diphtheria, Date of authorisation: 17/04/2013, Date of refusal: 22/02/2013, Revision: 19, Status: Authorised

Case Medical Research ◽

10.31525/cmr-14481fe ◽

2019 ◽

Author(s):

Keyword(s):

Hepatitis B ◽

Haemophilus Influenzae ◽

Whooping Cough ◽

Haemophilus Influenzae Type ◽

Haemophilus Influenzae Type B ◽

Type B ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Tetanus Immunization

Download Full-text

Human medicines European public assessment report (EPAR): Vaxelis, diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA), poliomyelitis (inactivated) and Haemophilus type b conjugate vaccine (adsorbed), Meningitis, Haemophilus,Poliomyelitis,Tetanus,Diphtheria,Whooping Cough,Hepatitis B, Date of authorisation: 15/02/2016, Revision: 6, Status: Authorised

Case Medical Research ◽

10.31525/cmr-bb17b9 ◽

2019 ◽

Author(s):

Keyword(s):

Hepatitis B ◽

Conjugate Vaccine ◽

Whooping Cough ◽

Type B ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text